COVID Booster in Pregnancy and Lactation

Description

This is a prospective longitudinal cohort study to evaluate the impact of COVID-19 vaccination and booster on maternal and infant immunity against COVID-19 variants over time.

Conditions

COVID-19

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a prospective longitudinal cohort study to evaluate the impact of COVID-19 vaccination and booster on maternal and infant immunity against COVID-19 variants over time.

Serological and Functional Impact of COVID-19 Vaccination on the Maternal Fetal Unit and Infant Immunity

COVID Booster in Pregnancy and Lactation

Condition
COVID-19
Intervention / Treatment

-

Contacts and Locations

Philadelphia

Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States, 19107

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Singleton gestation
  • * Received mRNA bivalent COVID-19 booster during 1) pregnancy or 2) breastfeeding
  • * Multifetal gestation
  • * Unable to provide consent

Ages Eligible for Study

13 Years to 55 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Thomas Jefferson University,

Rupsa C Boelig, MD, PRINCIPAL_INVESTIGATOR, Thomas Jefferson University

Study Record Dates

2025-03-01